Sana Biotechnology Stock Forecast, Price & News

Sana Biotechnology (NASDAQ:SANA) Frequently Asked Questions

Is Sana Biotechnology a buy right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sana Biotechnology in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Sana Biotechnology stock.
View analyst ratings for Sana Biotechnology or view top-rated stocks.

Are investors shorting Sana Biotechnology?

Sana Biotechnology saw a increase in short interest in the month of December. As of December 31st, there was short interest totaling 9,790,000 shares, an increase of 23.6% from the December 15th total of 7,920,000 shares. Based on an average trading volume of 590,100 shares, the short-interest ratio is currently 16.6 days. Currently, 12.8% of the shares of the stock are sold short.
View Sana Biotechnology's Short Interest.

When is Sana Biotechnology's next earnings date?

Sana Biotechnology is scheduled to release its next quarterly earnings announcement on Wednesday, March 23rd 2022.
View our earnings forecast for Sana Biotechnology.

How were Sana Biotechnology's earnings last quarter?

Sana Biotechnology, Inc. (NASDAQ:SANA) issued its quarterly earnings data on Sunday, November, 7th. The company reported ($0.46) earnings per share for the quarter, beating analysts' consensus estimates of ($0.49) by $0.03.
View Sana Biotechnology's earnings history.

What price target have analysts set for SANA?

4 analysts have issued 12 month price objectives for Sana Biotechnology's stock. Their forecasts range from $34.00 to $45.00. On average, they expect Sana Biotechnology's stock price to reach $38.50 in the next year. This suggests a possible upside of 352.4% from the stock's current price.
View analysts' price targets for Sana Biotechnology or view top-rated stocks among Wall Street analysts.

Who are Sana Biotechnology's key executives?

Sana Biotechnology's management team includes the following people:

• Dr. Steven D. Harr, Pres, CEO & Director (Age 51, Pay $829.25k)
• Dr. Richard C. Mulligan, Exec. Vice Chairman & Head of SanaX (Age 66, Pay $954.45k)
• Mr. Christian Hordo M.B.A., Sr. VP & Chief Bus. Officer (Age 38, Pay $485.03k) (LinkedIn Profile)
• Mr. Nathan Hardy M.B.A., Sr. VP & CFO (Age 45)
• Ms. Shanna Clouse Peek, Sr. VP & Head of Corp. Operations
• Brittany Mccleery, Accounting Mang.
• Dr. Edward Rebar Ph.D., Sr. VP & CTO (Age 53)
• Mr. James J. MacDonald J.D., Exec. VP, Gen. Counsel & Sec. (Age 46)
• Ms. Robin Andrulevich, Exec. VP & Chief People Officer (Age 55)
• Dr. Sunil Agarwal, Exec. VP, Head of Devel. & Chief Medical Officer (Age 51)

Who are some of Sana Biotechnology's key competitors?

Some companies that are related to Sana Biotechnology include Novavax (NVAX), Exelixis (EXEL), CRISPR Therapeutics (CRSP), Halozyme Therapeutics (HALO), Beam Therapeutics (BEAM), Denali Therapeutics (DNLI), Vir Biotechnology (VIR), Abcam (ABCM), Ablynx (ABLYF), Fate Therapeutics (FATE), Kodiak Sciences (KOD), SpringWorks Therapeutics (SWTX), Twist Bioscience (TWST), BioCryst Pharmaceuticals (BCRX) and Relay Therapeutics (RLAY).
View all of SANA's competitors.

When did Sana Biotechnology IPO?

(SANA) raised $322 million in an initial public offering (IPO) on Thursday, February 4th 2021. The company issued 15,000,000 shares at a price of $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs, J.P. Morgan and BofA Securities served as the underwriters for the IPO.

What is Sana Biotechnology's stock symbol?

Sana Biotechnology trades on the NASDAQ under the ticker symbol "SANA."

Who are Sana Biotechnology's major shareholders?

Sana Biotechnology's stock is owned by a number of retail and institutional investors. Top institutional investors include Baillie Gifford & Co. (5.96%).
View institutional ownership trends for Sana Biotechnology.

Which major investors are buying Sana Biotechnology stock?

SANA stock was bought by a variety of institutional investors in the last quarter, including Baillie Gifford & Co..
View insider buying and selling activity for Sana Biotechnology or or view top insider-buying stocks.

How do I buy shares of Sana Biotechnology?

Shares of SANA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sana Biotechnology's stock price today?

One share of SANA stock can currently be purchased for approximately $8.51.

How much money does Sana Biotechnology make?

Sana Biotechnology has a market capitalization of $1.61 billion. The company earns $-285.30 million in net income (profit) each year or ($9.29) on an earnings per share basis.

How many employees does Sana Biotechnology have?

Sana Biotechnology employs 265 workers across the globe.

What is Sana Biotechnology's official website?

The official website for Sana Biotechnology is sana.com.

Where are Sana Biotechnology's headquarters?

Sana Biotechnology is headquartered at 188 EAST BLAINE STREET SUIT 400, SEATTLE WA, 98102.

How can I contact Sana Biotechnology?

Sana Biotechnology's mailing address is 188 EAST BLAINE STREET SUIT 400, SEATTLE WA, 98102. The company can be reached via phone at 206-701-7914 or via email at [email protected].